A 52 WEEKS RETROSPECTIVE STUDY OF DUPILUMAB TREATMENT FOR MODERATE TO SEVERE ATOPIC DERMATITIS IN KOREA: LONG-TERM EFFICACY AND SAFETY OF DUPILUMAB IN REAL WORLD PRACTICE

被引：0
|
作者：
Ahn, Jiyoung [1 ]
Jang, Dong Hyek [1 ]
Heo, Seok Jae [2 ]
Lee, Dong Heon [1 ]
Jung, Hye Jung [1 ]
Park, Mi Yeon [1 ]
Seo, Seoung Jun [3 ]
机构：
[1] Natl Med Ctr, Dept Dermatol, Seoul, South Korea
[2] Yonsei Univ, Dept Biostat & Comp, Grad Sch, Seoul, South Korea
[3] Chung Ang Univ, Dept Dermatol, Coll Med, Seoul, South Korea
来源：
ACTA DERMATO-VENEREOLOGICA | 2021年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
OL9
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [41] Long-term dupilumab treatment up to 100 weeks reduces serum biomarkers in adult patients with moderate-to-severe atopic dermatitis
    Beck, L. A.
    Thaci, D.
    Bissonnette, R.
    Deleuran, M.
    Bastian, M.
    Harel, S.
    Chen, Z.
    Levit, N. A.
    Rossi, A. B.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 55 - 56
  • [42] Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
    Sroka-Tomaszewska, Jowita
    Bulinska, Barabara
    Wilkowska, Aleksandra
    Nowicki, Roman J.
    Trzeciak, Magdalena
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2023, 40 (06): : 747 - 752
  • [43] Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience
    Martinez-Domenech, A.
    Zaragoza-Ninet, V.
    Esteve-Martinez, A.
    Garcia-Rabasco, A.
    Sanchez-Carazo, J. L.
    Perez-Ferriols, A.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (02): : 150 - 158
  • [44] Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients
    Ferrucci, Silvia
    Tavecchio, Simona
    Maronese, Carlo Alberto
    Balato, Anna
    Di Brizzi, Eugenia Veronica
    Ortoncelli, Michela
    Ribero, Simone
    Girolomoni, Giampiero
    Maurelli, Martina
    Fortina, Anna Belloni
    Caroppo, Francesca
    Naldi, Luigi
    Pezzolo, Elena
    Nettis, Eustachio
    Pugliese, Francesco
    Stingeni, Luca
    Hansel, Katharina
    Rubegni, Giovanni
    Calabrese, Laura
    Russo, Filomena
    Gola, Massimo
    Magnaterra, Elisabetta
    Rongioletti, Franco
    Mercuri, Santo Raffaele
    Paolino, Giovanni
    Savoia, Paola
    Veronese, Federica
    Foti, Caterina
    Ambrogio, Francesca
    Scalvenzi, Massimiliano
    Napolitano, Maddalena
    Patruno, Cataldo
    Dastoli, Stefano
    Corazza, Monica
    Borghi, Alessandro
    Calzavara-Pinton, Pier Giacomo
    Rossi, Mariateresa
    Offidani, Annamaria
    Radi, Giulia
    Bonzano, Laura
    Ferreli, Caterina
    Piras, Viviana
    Satta, Rosanna
    Sucato, Federica
    Malagoli, Piergiorgio
    Gaiani, Francesca
    Micali, Giuseppe
    Musumeci, Maria Letizia
    Fargnoli, Maria Concetta
    Esposito, Maria
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [45] Laboratory safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: Open-Label Extension (OLE) study
    Blauvelt, A.
    Wollenberg, A.
    Chen, Z.
    Bastian, M.
    Zhang, M.
    Khokhar, F. A.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 65 - 66
  • [46] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
    Mareschal, Adrien
    Puzenat, Eve
    Aubin, Francois
    [J]. ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
  • [47] Efficacy of Dupilumab on Different Phenotypes of Adult with Moderate-to-Severe Atopic Dermatitis in Taiwan: A Real-World Study
    Yang, Chin-Yi
    Lai, Po-Ju
    Chen, Chun-Bing
    Chan, Tom C.
    Hui, Rosaline Chung-Yee
    Huang, Yu-Huei
    Tseng, Han-Chi
    Lin, Shang-Hung
    Lu, Chun-Wei
    Lee, Hua-En
    Lin, Jing-Yi
    Chi, Min-Hui
    Tsai, Ming-Feng
    Hwang, Yih-Shiou
    Wang, Chuang-Wei
    Chu, Chia-Yu
    Chung, Wen-Hung
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [48] LONG-TERM EFFICACY AND SAFETY OF DUPILUMAB IN REAL CLINICAL PRACTICE: SINGLE CENTER STUDY
    Lee, Yang Won
    Lim, Ji Won
    Yoon, Yi Na
    Sung, Jae Young
    Son, Hyung Seok
    Kim, Chang Yong
    Cho, Young Ah
    Yu, Da-Ae
    Choe, Yong Beom
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 52 - 52
  • [49] Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China
    Peng, Cong
    Cao, Qiaozhi
    Xiong, Feng
    Xu, Hui
    Li, Jie
    [J]. MEDCOMM, 2024, 5 (10):
  • [50] Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
    Berna-Rico, Emilio
    Fiz-Benito, Esther
    Busto-Leis, Jose Manuel
    Servera-Negre, Guillermo
    de Lucas-Laguna, Raul
    Feito-Rodriguez, Marta
    [J]. DERMATOLOGY, 2024, 240 (02) : 337 - 342
12345